低氧预处理人脂肪间充质干细胞联合脐血单核细胞治疗大鼠急性心肌梗死
本文选题:低氧预处理 + 脂肪间充质干细胞 ; 参考:《中国人民解放军医学院》2016年博士论文
【摘要】:[背景]心肌梗死是严重威胁人类健康的疾病。我国每年约有2.9亿人罹患心血管疾病,并有350万人因此而丧生。心血管疾病死亡率位居我国城乡居民总死亡原因的首位,且呈逐年攀升趋势。目前心肌梗死的主要治疗手段还是药物和手术,虽然它们能够促进血管再通,减轻心肌的持续性损伤,但二者对梗死的心肌组织并无再生作用,且不能有效逆转心肌梗死后的纤维化。干细胞移植是一种新兴的治疗方法,其目的是促进缺血区心肌和血管生成,减少心肌细胞凋亡,减轻心室重塑。脂肪间充质干细胞(Adipose-derived mesenchymal stem cells,ASC)以其独特的优势,逐渐成为当前研究的热点。虽然ASC的安全性和有效性已得到初步认识,但其在体内的存活和显效还受到多个环节的影响。为了提高干细胞在局部的存活效率,研究者们开始对干细胞进行体外预处理或者对组织微环境进行改善,以利于细胞的长期存活和发挥修复功能。低氧预处理(Hypoxia precondition,HP)是增加干细胞存活率的简单有效的方法。为了适应移植后在梗死区局部的低氧环境,在体外对ASC进行低氧培养,以此增强细胞对低氧的耐受性和抗凋亡能力,同时促进其分泌多种生长因子,有利于细胞进入体内后发挥修复和再生功能。脐血单核细胞(Cord blood mononuclear cells,CBMNCs)能够促进血管新生和血管内皮化,改善梗死局部的微循环。内皮细胞的再血管化可以为移植的干细胞带来营养和氧气,有利于干细胞在局部的存活。因此,将体外预处理与体内微环境的改善结合起来,可能更有利于细胞在局部的长期存活。[目的]1.研究ASC的培养,鉴定和体外诱导分化能力;以及CBMNCs分离和冻存备用;2.检测低氧预处理前后ASC的基因表达变化;并体外模拟心梗环境培养HP-ASC和ASC,比较二者基因表达水平的变化;3.评价HP-ASC治疗大鼠心肌梗死是否优于ASC;4.评价HP-ASC联合CBMNCs治疗大鼠心肌梗死是否优于单一细胞移植效果。[方法]1.以健康成人脂肪抽吸术后的脂肪组织为实验对象,用胶原酶消化分解后,离心取下层SVF细胞,接种培养。用MTT法测量细胞密度并绘制ASC生长曲线;流式细胞术检测ASC细胞表面标记;分别以成骨、成脂、成软骨诱导液诱导ASC分化,利用组织化学染色和免疫蛆化染色检测其多向分化潜能。来自健康婴儿的脐血离心沉降法分离出CBMNCs,检测细胞数量及活性细胞比例,冻存备用。2.ASC在低氧(2%O2)条件下培养24h,提取细胞RNA,比较HP-ASC与未处理ASC基因表达情况;模拟体内心梗局部微环境,取大鼠心梗后3d的心脏组织,研磨成浆,加入血清及必须氨基酸等配制成心梗混合液。将HP-ASC和ASC在此混合液中培养5d,检测细胞在微环境诱导下基因表达的变化;3.两月龄Wistar雌性大鼠30只,按照随机数法将实验动物随机分为3组,HP-ASC组,ASC组和PBS组,每组各10只大鼠。结扎冠状动脉左前降支建立心肌梗死损伤模型,动物心梗后即刻心肌内注射干细胞(总量:2×106)或PBS。细胞移植后7d和15d每组分别处死5只大鼠,收集心脏组织,制作冰冻组织切片和石蜡组织切片。比较各组之间心梗部位的大体形态学变化,心梗区占左心室比例,细胞移植效率,细胞凋亡数量和新生血管密度。4. 两月龄Wistar雌性大鼠60只,按照随机数法将实验动物随机分为4组,HP-ASC组,HP-ASC+CBMNCs组,CBMNCs组和PBS组,每组各15只大鼠。模型成功后即刻进行细胞移植,细胞总量为2×106(联合组细胞比例1:1)。每组动物分别在手术后7d,15d和30d各取5只处死。比较各组之间心梗部位的大体形态学变化,心梗区占左心室比例和室壁厚度,细胞移植存活率和新生血管密度。[结果]1.原代ASC接种6h后,部分细胞开始贴壁生长,24-48h后细胞开始出现集落样增长(CFU)。第3代以后,细胞呈典型纤维母细胞样梭形外观,开始呈漩涡状生长,MTT法检测显示,ASC的对数生长期为3-7d,第8d开始进入平台期。流式细胞术检测结果表明,ASC细胞表达CD34(-)/CD45(-)/CD90(+)/CD105(+) /CD73(+)/CD44(+),符合间充质干细胞表型。诱导分化试验表明,ASC可以向成脂、成骨和成软骨方向分化。CBMNCs分离后,单核细胞数量达到8.9×109,活性细胞计数结果显示,活性细胞数占所有有核细胞的93.16%。2. 与ASC相比,HP-ASC表达多种生长因子及其受体水平增高,与干细胞特性相关的基因Klf4和Oct4略有增高,而Nanog和Sox2表达却较后者有所降低。此外,HP-ASC中与低氧诱导表达相关的基因--血红素加氧酶-1(Heme oxygenase-1,HO-1)和基质细胞衍生因子-1(Stromal cell derived factor-1,SDF-1)均表达增高,分别为ASC组的1.38倍和1.98倍。与细胞迁移和植入相关的基因,除金属蛋白酶组织抑制剂(Tissue inhibitor of metalloproteinase,TIMP-1)下降外,趋化因子受体-4(CXCR4),细胞间粘附分子(Intercellular cell adhesion molecule, ICAM-1和ICAM-2)的表达都有所增加。体外模拟心梗环境培养可以促进HP-ASC-T表达心肌特异性标志物(CX43, FABP4, GATA-4)和促血管生长因子(VEGF),同时也可促进HP-ASC-T表达多种生长因子及其受体。3. 动物试验表明,与PBS组相比,HP-ASC组和ASC组在心梗后7d及15d均可显著减少心梗面积,增加细胞存活数量,减少凋亡细胞数量,以及显著增加新生血管数量。而HP-ASC组较ASC组改善更为明显。4.心梗大鼠进行细胞移植后30天,HP-ASC组,HP-ASC+CBMNCs组和CBMNCs组均比PBS组明显改善了心功能。其中,HP-ASC组改善效果更好。组织学检测表明,HP-ASC组的心梗比例和心梗室壁厚度,细胞存活数量和新生血管数量均比其他对照组改善更好。[结论]1.本实验所培养ASC细胞表达CD34 (-)/CD45 (-)/CD90 (+)/CD105 (+)/CD73 (+)/CD44 (+),符合间充质干细胞表型。ASC有多向分化潜能,经体外诱导可向成骨、成脂、成软骨方向分化。离心沉降法可获得临床级数量的CBMNCs,分离后细胞存活率高。2.低氧预处理后,HP-ASC表达多种生长因子及其受体升高。模拟体内心梗局部微环境可使HP-ASC表达心肌特异性标志物、促血管生成因子和生长因子水平升高。3. 与ASC相比,HP-ASC可以更有效地减少大鼠的心梗面积,增加细胞存活比例,减少心梗区细胞凋亡数量,增加新生血管数量。4. HP-ASC对心梗大鼠心功能的改善效果比HP-ASC+CBMNCs组和CBMNCs组更好,其心梗比例和心梗室壁厚度,细胞存活数量和新生血管数量均比其他对照组改善更好。
[Abstract]:[background] myocardial infarction is a serious threat to human health. About 290 million people are suffering from cardiovascular disease every year, and 3 million 500 thousand people have died. The mortality of cardiovascular disease is the first leading cause of death in urban and rural areas in China, and is increasing year by year. At present, the main treatment means of myocardial infarction are drugs and surgery. However, they can promote vascular recanalization and reduce persistent myocardial damage, but the two have no regenerative effect on the infarcted myocardium and can not effectively reverse the fibrosis after myocardial infarction. Stem cell transplantation is a new method to promote the formation of myocardial and vascularization in the ischemic region, reduce the apoptosis of myocardial cells and reduce the ventricles. Remolding. Adipose-derived mesenchymal stem cells (ASC) has become a hot spot of current research because of its unique advantages. Although the safety and effectiveness of ASC have been preliminarily recognized, the survival and effectiveness of ASC in the body are affected by many links. Hypoxia precondition (HP) is a simple and effective way to increase the survival rate of stem cells. In order to adapt to the hypoxic environment in the infarct area, ASC in vitro can be used in vitro. Cord blood mononuclear cells (CBMNCs) can promote the angiogenesis and endothelialization of blood vessels and improve the local micro level of infarct. The revascularization of endothelial cells can bring nutrients and oxygen to the transplanted stem cells and help the stem cells to survive locally. Therefore, the combination of in vitro pretreatment and the improvement of the microenvironment in the body may be more beneficial to the long-term survival of the cells. [Objective]1. to study ASC culture, identification and differentiation ability in vitro; And CBMNCs separation and cryopreservation; 2. detection of ASC gene expression changes before and after hypoxia preconditioning; and in vitro simulated myocardial infarction environment to cultivate HP-ASC and ASC, compare the changes in the level of gene expression in the two groups; 3. evaluate whether HP-ASC is superior to ASC in the treatment of myocardial infarction in rats; 4. evaluation of HP-ASC combined CBMNCs in the treatment of myocardial infarction in rats is better than that. [method]1. with the adipose tissue after liposuction of healthy adult as the experimental object, after digestion with collagenase, the lower SVF cells were centrifuged and cultured. The cell density was measured by MTT method and the growth curve of ASC was plotted, and the flow cytometry was used to detect the surface markers of ASC cells; the osteogenesis, fat formation, and cartilage induction were respectively induced by flow cytometry. ASC differentiation was induced by the guide solution, and the multidirectional differentiation potential was detected by histochemical staining and immungo-magma staining. CBMNCs was isolated from the umbilical blood centrifugation method from healthy infants. The number of cells and the proportion of active cells were detected. The frozen reserve.2.ASC was incubated with 24h under the condition of 2%O2, and the RNA was extracted and compared with the HP-ASC and the untreated ASC gene table. To simulate the local microenvironment of myocardial infarction in the body, the heart tissue of 3D after myocardial infarction was taken after the rat myocardial infarction, pulping, adding serum and essential amino acids into the mixture of myocardial infarction. HP-ASC and ASC were cultured in the mixture of 5D to detect the change of gene expression under the induction of microenvironment; 3. 2 month old Wistar female rats, according to random The experimental animals were randomly divided into 3 groups, group HP-ASC, group ASC and group PBS, each group of 10 rats. The left anterior descending branch of the coronary artery was ligated to establish the myocardial infarction damage model. After the animal myocardial infarction was injected into the myocardium immediately after the injection of stem cells (total: 2 * 106) or PBS. cells, 5 rats were killed in each group of 7D and 15d respectively, and the heart tissue was collected and frozen to make freezing. Tissue section and paraffin tissue section were used to compare the gross morphological changes of the myocardial infarction parts, the proportion of the left ventricle in the myocardial infarction area, the cell transplantation efficiency, the number of cell apoptosis and the.4. 2 month old Wistar female rats. The experimental animals were divided into 4 groups according to the random number method, group HP-ASC, HP-ASC+CBMNCs group and CBMNCs group. And group PBS, 15 rats in each group. After the model was successfully transplanted, the total cell total was 2 x 106 (1:1). Each group was killed in 7d, 15d and 30d after operation respectively. The gross morphological changes of the myocardial infarction areas were compared, the ratio of the left ventricle and the wall thickness, and the survival rate of cell transplantation were compared. After]1. primary ASC was inoculated with 6h, some cells began to grow on the wall after 6h. After 24-48h, the cells began to appear colony like growth (CFU). After the third generation, the cells showed a typical fibroblast like appearance, and began to be whirlpool. The MTT method showed that the logarithmic growth period of ASC was 3-7d, and the 8D began to enter the platform stage. Flow formula began to flow. The results of cytometry showed that ASC cells expressed CD34 (-) /CD45 (+) /CD90 (+) /CD105 (+) /CD73 (+) /CD44 (+), which conformed to the phenotype of mesenchymal stem cells. Induced differentiation test showed that ASC could be turned into fat, bone formation and chondrogenic differentiation, and the number of mononuclear cells reached 8.9 * 109, and the number of active cells showed that the number of active cells accounted for the number of active cells. Compared with ASC, HP-ASC expressed a variety of growth factors and their receptor levels in HP-ASC, and a slight increase in Klf4 and Oct4 genes related to the characteristics of stem cells, but the expression of Nanog and Sox2 was lower than that of the latter. In addition, the genes associated with hypoxia induced expression in HP-ASC, -1 (Heme oxygenase-1, HO-1), were associated with hypoxia. The expression of -1 (Stromal cell derived factor-1, SDF-1) was increased by 1.38 and 1.98 times, respectively, in the ASC group. The expression of tercellular cell adhesion molecule, ICAM-1 and ICAM-2 increased. In vitro simulated myocardial infarction environment culture can promote the expression of HP-ASC-T specific markers (CX43, FABP4, GATA-4) and vascular growth factor (VEGF), and also promote the expression of a variety of growth factors and their receptors in HP-ASC-T. Compared with group S, 7d and 15d in group HP-ASC and ASC can significantly reduce the area of myocardial infarction, increase the number of cell survival, decrease the number of apoptotic cells, and significantly increase the number of new blood vessels. The improvement of HP-ASC group is more obvious than that of the ASC group, and 30 days after the transplantation of.4. myocardial infarction rats, HP-ASC group, HP-ASC+CBMNCs group and CBMNCs group are all more than PBS group. Significantly improved cardiac function. Among them, the HP-ASC group improved the effect better. Histological examination showed that the ratio of myocardial infarction in group HP-ASC and the thickness of myocardial infarction room wall, the number of cell survival and the number of neovascularization were better than those of the other control groups. [conclusion the ASC cells cultured in this experiment are CD34 (-) /CD45 (+) /CD105 (+) /CD73 (+) /CD44 (+) (+), +) of CD34 (-) /CD45 (+) /CD105 (+). The phenotype of mesenchymal stem cells (.ASC) has multipotential differentiation potential, which can be induced to osteogenesis, fat formation and chondrogenic differentiation in vitro. Centrifuge sedimentation can obtain a clinical level of CBMNCs. After separation, the cell survival rate is high.2. hypoxia preconditioning, HP-ASC expresses a variety of growth factors and their receptors increase. The local microenvironment of myocardial infarction can be simulated in vivo. HP-ASC expressed the specific markers of cardiac muscle, and increased the level of angiogenic factor and growth factor of.3. compared with ASC. HP-ASC could reduce the area of myocardial infarction more effectively, increase the proportion of cell survival, reduce the number of apoptosis in myocardial infarction area, and increase the effect of.4. HP-ASC on cardiac function of myocardial infarction rats than HP-ASC+CBM Group NCs and group CBMNCs were better, and their myocardial infarction ratio and myocardial infarction wall thickness, cell survival and neovascularization were all better than those of other control groups.
【学位授予单位】:中国人民解放军医学院
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R542.22
【相似文献】
相关期刊论文 前10条
1 本刊编辑部;;我国首家间充质干细胞库在天津落成[J];中国药业;2006年07期
2 张鑫;赵桂秋;;间充质干细胞在眼科领域的研究与应用[J];中国组织工程研究与临床康复;2009年06期
3 史春梦;;间充质干细胞表述中需要注意的几个问题[J];第三军医大学学报;2009年14期
4 瞿海龙;边剑飞;张冰;王颖;周英莲;;间充质干细胞临床应用的前景与困惑[J];医学研究与教育;2011年05期
5 郭子宽;;间充质干细胞及其临床应用中的几个问题[J];中国组织工程研究;2012年01期
6 李炳尧;武晓云;吴岩;;间充质干细胞的分离与培养:从实验室到临床[J];中国组织工程研究;2013年14期
7 吴实;邓列华;;皮肤间充质干细胞在促进皮肤愈合中的作用[J];实用皮肤病学杂志;2013年03期
8 吴清法,王立生,吴祖泽;间充质干细胞的来源及临床应用[J];军事医学科学院院刊;2002年03期
9 黄定强;间充质干细胞的研究进展[J];国外医学(耳鼻咽喉科学分册);2003年03期
10 付文玉,路艳蒙,乔东访,朴英杰;运用组织工程学原理构建间充质干细胞的三维培养体系[J];潍坊医学院学报;2003年03期
相关会议论文 前10条
1 陈可;王丁;韩之波;朱德林;韩忠朝;;人脐带间充质干细胞体外发挥免疫活性的研究[A];第12届全国实验血液学会议论文摘要[C];2009年
2 金明顺;张毅;贾秀芬;周燕华;闫妍;刘慧雯;;小鼠脂肪间充质干细胞的分离、培养以及多潜能分化的研究[A];中国解剖学会第十一届全国组织学与胚胎学青年学术研讨会论文汇编[C];2009年
3 李争艳;刘杨;翟丽丽;杨迷玲;王立峰;;间充质干细胞在肿瘤发展过程中的作用[A];中华医学会病理学分会2009年学术年会论文汇编[C];2009年
4 张彦;李尚珠;;间充质干细胞在血管工程中的机制及应用[A];2009全国中西医结合周围血管疾病学术交流会论文集[C];2009年
5 石玉;戴\戎;;周期性拉应力对间充质干细胞分化影响的研究[A];第九届全国生物力学学术会议论文汇编[C];2009年
6 黎娇;朱争艳;杜智;骆莹;王鹏;高英堂;;人脐带间充质干细胞分泌物对肝细胞增殖和凋亡的影响[A];天津市生物医学工程学会第30次学术年会暨生物医学工程前沿科学研讨会论文集[C];2010年
7 谭远超;Kevin;姜红江;黄相杰;周纪平;;间充质干细胞在骨伤疾病治疗中的应用[A];首届全国中西医结合骨科微创学术交流会暨专业委员会成立大会论文汇编[C];2011年
8 唐佩弦;;间充质干细胞及其临床应用前景[A];第三届全国血液免疫学学术大会论文集[C];2003年
9 戴育成;;间充质干细胞的生物学特性和应用[A];2005年华东六省一市血液病学学术会议暨浙江省血液病学学术年会论文汇编[C];2005年
10 胡琳莉;王昕荣;钱坤;李舟;杨薇;朱桂金;;小鼠间充质干细胞向子宫内膜分化的实验研究[A];第一届中华医学会生殖医学分会、中国动物学会生殖生物学分会联合年会论文汇编[C];2007年
相关重要报纸文章 前10条
1 满学杰;天津滨海新区建最大间充质干细胞生产基地[N];新华每日电讯;2008年
2 满学杰;津昂赛打造间充质干细胞生产基地[N];医药经济报;2008年
3 第三军医大学西南医院输血科 李忠俊 整理 吴刘佳;间充质干细胞研究又见新方法[N];健康报;2013年
4 上海生科院 上海交大医学院健康科学研究所 曹楷;间充质干细胞:干细胞中的孙悟空[N];上海科技报;2014年
5 记者 陈建强;首家间充质干细胞库在津建成[N];光明日报;2006年
6 记者 冯国梧;细胞产品国家工程中心建设方案获准[N];科技日报;2007年
7 实习生 刘霞;间充质干细胞有望用于面部整形[N];科技日报;2007年
8 本报记者 王新佳;我国“原始间充质干细胞”注射液进入临床研究[N];中国高新技术产业导报;2005年
9 冯国梧;全球首个脐带间充质干细胞库规模化运营[N];科技日报;2008年
10 刘莹清;全球首个脐带间充质干细胞库泰达规模运营[N];北方经济时报;2008年
相关博士学位论文 前10条
1 王皓;五指山小型猪OCT-4、SOX-2基因在骨髓间充质与脐带间充质干细胞中的过表达研究[D];中国农业科学院;2013年
2 孔德晓;间充质干细胞及胰岛素分泌细胞治疗糖尿病的临床及应用基础研究[D];山东大学;2015年
3 董苑;SDF-1复合PDPBB的构建及对间充质干细胞趋化影响的研究[D];昆明医科大学;2015年
4 王磊;诱导胎盘来源间充质干细胞向成牙骨质细胞分化的实验研究[D];山东大学;2015年
5 房贺;连接黏附分子A在促进MSC修复CC14肝损伤中的作用及其机制[D];第二军医大学;2015年
6 陈洁;间充质干细胞外泌体对急性肺损伤小鼠的影响及相关机制的实验研究[D];中国人民解放军医学院;2015年
7 许婷;转化生长因子β1在蟑螂过敏原诱导的哮喘中对间充质干细胞募集迁移的影响[D];南方医科大学;2015年
8 周雅丽;携氧间充质干细胞对胃癌化疗效果的影响及其机制研究[D];兰州大学;2015年
9 沈舒宁;CKIP-1负调控间充质干细胞成骨分化研究[D];第四军医大学;2015年
10 姚惟琦;脂肪来源间充质干细胞治疗急性肾损伤[D];武汉大学;2015年
相关硕士学位论文 前10条
1 顾立超;BTK抑制剂对间充质干细胞miR-21的调节作用[D];河北联合大学;2014年
2 王文杰;鸭胚间充质干细胞生物学特性及其移植修复肝损伤研究[D];中国农业科学院;2015年
3 张猛;血管内皮前体细胞对间充质干细胞分化潜能的影响[D];石河子大学;2015年
4 马丽媛;利用MyoD基因诱导绵羊脐带间充质干细胞分化为成肌细胞的研究[D];东北林业大学;2015年
5 宋维文;MicroRNA-133诱导绵羊间充质干细胞分化为成肌细胞的研究[D];东北林业大学;2015年
6 韩丽鑫;人脐带来源的间充质干细胞对耐维甲酸的早幼粒白血病细胞分化的研究[D];北京协和医学院;2015年
7 陶利;绵羊脐带和羊水间充质干细胞的分禽培养及鉴定[D];内蒙古大学;2015年
8 陈以胜;亚低温对颅脑创伤微环境下温敏脐带间充质干细胞分化特性影响的研究[D];河北医科大学;2015年
9 夏勇;人脐带间充质干细胞抑制HepG2作用优化方法探索[D];内蒙古大学;2015年
10 罗永慧;Pax6对大鼠脂肪间充质干细胞的分化诱导作用及其应用研究[D];成都医学院;2015年
,本文编号:2093468
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2093468.html